Marksans Pharma Limited

NSE MARKSANS.NS

Marksans Pharma Limited Interest Coverage Ratio for the year ending March 31, 2024: 38.80

Marksans Pharma Limited Interest Coverage Ratio is 38.80 for the year ending March 31, 2024, a 2.14% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Marksans Pharma Limited Interest Coverage Ratio for the year ending March 31, 2023 was 37.99, a -20.00% change year over year.
  • Marksans Pharma Limited Interest Coverage Ratio for the year ending March 31, 2022 was 47.49, a -46.91% change year over year.
  • Marksans Pharma Limited Interest Coverage Ratio for the year ending March 31, 2021 was 89.44, a 167.93% change year over year.
  • Marksans Pharma Limited Interest Coverage Ratio for the year ending March 31, 2020 was 33.38, a 73.55% change year over year.
Key data
Date Interest Coverage Ratio Debt to Equity Ratio Interest Expense To Sales Inventory Turnover Ratio
Market news
Loading...
SV Wall Street
NSE: MARKSANS.NS

Marksans Pharma Limited

CEO Mr. Mark B. Saldanha
IPO Date July 19, 2002
Location India
Headquarters Grandeur
Employees 1,141
Sector Healthcare
Industries
Description

Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Similar companies

MOREPENLAB.NS

Morepen Laboratories Limited

USD 0.67

-4.06%

APLLTD.NS

Alembic Pharmaceuticals Limited

USD 10.15

0.53%

GRANULES.NS

Granules India Limited

USD 6.50

-2.02%

SUVEN.NS

Suven Life Sciences Limited

USD 1.48

-1.17%

HFCL.NS

HFCL Limited

USD 1.12

-2.19%

StockViz Staff

February 12, 2025

Any question? Send us an email